Jiao Liu

11PUBLICATIONS
21CO-AUTHORS
Innate immunityCancer cell biologyAutonomic nervous systemMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 02, 2026
Immune Checkpoint Inhibitors and Immunomodulators for Cancer Immunotherapy: Insights Into Resistance and Therapeutic Strategies.

Fangquan Chen, Yang Yu, Xiutao Cai

|Jul 14, 2025
CYP51A1 in health and disease: from sterol metabolism to regulated cell death.

Fangquan Chen, RuiRui Liang, Jieting Zhang

|May 02, 2025
A neuroimmune pathway drives bacterial infection.

Nian Wang, Jiao Liu, Runliu Wu

|Mar 07, 2025
CYP51A1 drives resistance to pH-dependent cell death in pancreatic cancer.

Fangquan Chen, Hu Tang, Changfeng Li

|Jan 29, 2025
AGER-dependent macropinocytosis drives resistance to KRAS-G12D-targeted therapy in advanced pancreatic cancer.

Changfeng Li, Yuanda Liu, Chang Liu

|Jul 15, 2024
Macropinocytosis inhibits alkaliptosis in pancreatic cancer cells through fatty acid uptake.

Fangquan Chen, Hu Tang, Junhao Lin

Pageof 2

Frequent Collaborators

9 joint publications

Daolin Tang

6 joint publications

Rui Kang

4 joint publications

Chunhua Yu

3 joint publications

Runliu Wu